Ruby Lin

Adjunct A/Prof

PhD/MSc (Hons)/BSc

Ruby.lin@wimr.org.au

Centre for Infectious Diseases and Microbiology

Phage Therapy Group

Ruby Lin

Biography

Ruby Lin is an accomplished executive leader with over 25 years of experience in life sciences, biotechnology, and translational research. She has secured over AUD$17 million in funding, focusing on genomic medicine’s translation into clinical practice.

A passionate advocate for women in STEMM, Ruby mentors students and scientists, and contributes to various initiatives, including serving as the Genomic Chair for Westmead Research Precinct, holds executive roles in the Australasian Genomic Technologies Association and an independent school in NSW. Her expertise encompasses genomics, cardiovascular disease, cancer biology, and infectious diseases with more than 120 high-impact publications. Ruby actively engages in community service, including mentoring and pro bono career coaching, while also serving on several scientific journal editorial boards.

Research interests

Phage therapy, Translational research, Human transcriptomics, Clinical Genomics, Systems Biology

Adjunct roles

Adjunct Professor University of New South Wales
Adjunct Professor University of Sydney

Recent publications

Phage Biobank: Present Challenges and Future Perspectives. Current Opinions in Biotechnology

Bacterial lysis, autophagy and innate immune responses during adjunctive phage therapy in a child.

Safety of bacteriophage therapy in severe Staphylococcus aureus infection.

Standardised treatment and monitoring protocol to assess safety and tolerability of bacteriophage therapy for adult and paediatric patients (STAMP study): protocol for an open-label, single-arm trial.

Reduced PI3K induces atrial myopathy, and PI3K-related lipids are dysregulated in athletes with atrial fibrillation.

Current grants

NSW Statewide Biobanking Initiative 2019-2022 Pathogen & Phage Biobanks at Westmead
MRFF Frontiers Stage 1 2021-2022 JI and Phage Australia network.
Office of Health and Medical Research 2022 Australia: Education package for phage therapy (RL)
Office of Health and Medical Research 2023-2025 Australia: Securing sovereign manufacturing of phages in NSW
Hooper Shaw Foundation 2023-2026 AMR: bioprospecting and co-evolution. JI.

Affiliations

Westmead Hospital, University of Sydney

Professional Associations and Organisations

2003 to date Australasian Genomic Technologies Association Executive
2021-2023 Association of Australian Meical Research Institute Gender Equality, Diversity and Inclusion Committee member
2016 to date Science and Technology Australia AGTA member
2021 to date European Society of Clinical Microbiology & Infectious Diseases
2020 to date International Society for Viruses of Microorganisms Member, Conference Convenor for Virus of Microbes 2023
2018 to date Scientific Advisory Committee for Biobanking at Westmead Health Precinct Member
2018 to date Scientific Advisory Committee for Bioinformatics at Westmead Health Precinct Member
2018 to date Scientific Advisory Committee for Genomics at Westmead Health Precinct Chair since 2019
2023 to date Board of Directors, Hills Grammar School Executive member and Chair of DGR

Awards and recognition

2006-2009 NHMRC Peter Doherty Fellow
2010 - 2014 UNSW Vice-Chancellor Global Postdoctoral Fellow
2013-2015 President of AGTA
2020 to date Deputy Director of Phage Australia